Does SECUKINUMAB Cause Product dose omission? 932 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 932 reports of Product dose omission have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.6% of all adverse event reports for SECUKINUMAB.
932
Reports of Product dose omission with SECUKINUMAB
0.6%
of all SECUKINUMAB reports
1
Deaths
28
Hospitalizations
How Dangerous Is Product dose omission From SECUKINUMAB?
Of the 932 reports, 1 (0.1%) resulted in death, 28 (3.0%) required hospitalization, and 2 (0.2%) were considered life-threatening.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 932 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which SECUKINUMAB Alternatives Have Lower Product dose omission Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG